Literature DB >> 618387

Active valvulitis associated with chronic rheumatic valvular disease and active myocarditis.

W D Edwards, K Peterson, J E Edwards.   

Abstract

From ten patients aged 15 to 40 years with chronic rheumatic valvular disease and histologically proved Aschoff bodies of active rheumatic myocarditis, the valves were evaluated for incidence, distribution and degree of severity of active inflammation. Prior to death, there had been clinical evidence of active rheumatic fever. In each case, active rheumatic valvulitis was present in at least one valve. Of the individual valves studied, 83% were involved by active inflammation of the leaflets or the anulus or both. The aortic valves was involved in 100% of cases, the mitral valve in 86%, the tricuspid valve in 78% and the pulmonary valve in 70%. The mitral and aortic valves were most frequently involved, but the mitral and tricuspid valves were most severely involved when affected. In every case, active rheumatic lesions of the left atrial appendage were present, but these tended to be less widely distributed than the myocardial Aschoff bodies. The high incidence of active valvulitis supports the concept that chronic fibrosing rheumatic valvular disease results from recurrent active inflammation. Such inflammation may occur without clinical suspicion of active rheumatic fever.

Entities:  

Mesh:

Year:  1978        PMID: 618387     DOI: 10.1161/01.cir.57.1.181

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  4 in total

1.  Calcified rheumatic valve neoangiogenesis is associated with vascular endothelial growth factor expression and osteoblast-like bone formation.

Authors:  Nalini M Rajamannan; Thomas B Nealis; Malayannan Subramaniam; Sanjay Pandya; Stuart R Stock; Constatine I Ignatiev; Thomas J Sebo; Todd K Rosengart; William D Edwards; Patrick M McCarthy; Robert O Bonow; Thomas C Spelsberg
Journal:  Circulation       Date:  2005-06-13       Impact factor: 29.690

2.  [Morphological diagnosis: myocarditis (author's transl)].

Authors:  H Althoff
Journal:  Z Rechtsmed       Date:  1980

Review 3.  Medical therapy for rheumatic heart disease: is it time to be proactive rather than reactive?

Authors:  Nalini M Rajamannan; Francesco Antonini-Canterin; Luis Moura; Jose L Zamorano; Raphael A Rosenhek; Patricia Jm Best; Margaret A Lloyd; F Rocha-Goncalves; Sarat Chandra; Ottavio Alfieri; Patrizio Lancellotti; Pilar Tornos; Ragavendra R Baliga; Andrew Wang; Thomas Bashore; S Ramakrishnan; Konstantinos Spargias; Mony Shuvy; Ronen Beeri; Chaim Lotan; Jassim Al Suwaidi; Vinay Bahl; Luc A Pierard; Gerald Maurer; Gian Luigi Nicolosi; Shahbudin H Rahimtoola; K Chopra; Natesa G Pandian
Journal:  Indian Heart J       Date:  2009 Jan-Feb

Review 4.  Group A Streptococcus, Acute Rheumatic Fever and Rheumatic Heart Disease: Epidemiology and Clinical Considerations.

Authors:  Liesl J Zühlke; Andrea Beaton; Mark E Engel; Christopher T Hugo-Hamman; Ganesan Karthikeyan; Judith M Katzenellenbogen; Ntobeko Ntusi; Anna P Ralph; Anita Saxena; Pierre R Smeesters; David Watkins; Peter Zilla; Jonathan Carapetis
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.